GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,864.00
-49.00 (-2.56%)
Jun 9, 2026, 11:29 AM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 76.37 billion as of June 9, 2026. Its market cap has increased by 32.04% in one year.
Market Cap
76.37B
Enterprise Value
91.61B
Revenue
32.78B
Ranking
n/a
PE Ratio
13.47
Stock Price
1,864.00
Market Cap Chart
Since April 12, 2000, GSK plc's market cap has increased from 67.16B to 76.37B, an increase of 13.70%. That is a compound annual growth rate of 0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 77.36B | 5.69% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.94B |
| Haleon | 29.86B |
| Smith & Nephew | 9.80B |
| Convatec Group | 3.99B |
| Hikma Pharmaceuticals | 3.13B |
| Genus | 1.52B |
| HUTCHMED (China) | 1.39B |
| Oxford Nanopore Technologies | 1.27B |